India to Rwanda: Actinomycin Export Trade Route
India has recorded 15 verified shipments of Actinomycin exported to Rwanda, representing a combined trade value of $23.5K USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $1.6K USD. The leading Indian exporter is SEVATTO PHARMA, which accounts for 56% of total export value with 3 shipments worth $13.3K USD. On the buying side, TO THE ORDER OF is the largest importer in Rwanda with $13.3K USD in purchases. The top 3 suppliers — SEVATTO PHARMA, PNT PHARMA, PNT Pharma — together control 99% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Rwanda Actinomycin corridor is one of India's established pharmaceutical export routes, with 15 shipments documented worth a combined $23.5K USD. The route is dominated by SEVATTO PHARMA, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's actinomycin manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $1.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 83% of all shipments, consistent with actinomycin's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 16 days port-to-port. The route has recorded an annual growth rate of 17.5%, placing it at rank #6 among India's top actinomycin export destinations globally.
On the import side, key buyers of Indian actinomycin in Rwanda include TO THE ORDER OF, TO THE, BION PHARMA GROUP LIMITED and 1 others. TO THE ORDER OF is the single largest importer with 3 shipments valued at $13.3K USD.
